Bioelectronics Corporation (BIEL) Stock

About Bioelectronics Corporation

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.

Bioelectronics Corporation (BIEL) stock trades at $0.00 with a market capitalization of $7.41M. The stock is valued at price-to-sales of 7.41. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Bioelectronics Corporation generates a return on equity (ROE) of 5.56%, a net profit margin of -100.00%.

Official website: www.bielcorp.com